Pharmacokinetic and Pharmacodynamic Drug-Drug Interaction of Evogliptin and Empagliflozin or Dapagliflozin in Healthy Male Adults

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
A Randomized, Open‐label, Multiple‐dose, Crossover Study to Investigate the Pharmacokinetic and Pharmacodynamic Drug‐Drug Interaction of Evogliptin 5 mg and Empagliflozin 25 mg or Dapagliflozin 10 mg after Oral Administration in Healthy Male Adults
Epistemonikos ID: 54bed7c4b178e765eefcda4d600ed2303eb4e512
First added on: May 21, 2024